UK markets open in 57 minutes

Most Active SPACs

Most Active SPACs

6.53k followers31 symbols Watchlist by Yahoo Finance

Follow this list to discover and track the most active SPACs by daily trading volume.

Curated by Yahoo Finance

Follow this list to discover and track the most active SPACs by daily trading volume. Investopedia describes a special purpose acquisition company (SPAC) as "a company with no commercial operations that is formed strictly to raise capital through an initial public offering (IPO) for the purpose of acquiring an existing company." They are also known as "blank check companies."

SPACs revealed to investors and companies that there are faster and simpler ways to go public than a traditional IPO. If direct listings were previously the hype, SPACs are the new direct listing buzz today. In fact, SPACs have been around for decades and in recent years they have become more established as some notable companies have gone public through SPACs. Additionally, SPACs have attracted many high-profile names and investors which make them even more attractive.

The list includes stocks priced at $5 or more reflecting intraday volume. This list is generated daily and sorted by market cap; the gains are based on the latest closing price and limited to the top 30 stocks that meet the criteria.


Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the Global Financial Markets. We bring these insights to you in the form of watchlists.

Find other winning investment ideas with the Yahoo Finance Screener.

How are these weighted?

The stocks in this watchlist are weighted equally.


WatchlistChange today1-month return1-year returnTotal return
Most Active SPACs-1.30%---

31 symbols

SymbolCompany nameLast priceChange% changeMarket timeVolumeAvg vol (3-month)Market cap
CCIVChurchill Capital Corp IV21.73-0.36-1.63%16:00 GMT-411.71M48.04M5.62B
PSTHPershing Square Tontine Holdings, Ltd.24.67-0.05-0.20%16:00 GMT-41.56M3.88M4.93B
IPOESocial Capital Hedosophia Holdings Corp. V16.68-0.15-0.89%16:00 GMT-42.40M7.29M1.68B
AGCAltimeter Growth Corp.14.4-0.93-6.07%16:00 GMT-46.14M1.05M1.62B
IPOFSocial Capital Hedosophia Holdings Corp. VI10.55-0.09-0.85%16:00 GMT-41.68M4.69M1.52B
STPKStar Peak Energy Transition Corp.26.61-0.43-1.59%16:00 GMT-41.74M3.96M1.28B
GSAHGS Acquisition Holdings Corp II10.51-0.12-1.13%16:00 GMT-41.21M3.44M985.31M
AJAXAjax I10.11+0.03+0.30%16:00 GMT-4984.90k1.63M904.27M
BOWXBowX Acquisition Corp.12.45-1.10-8.12%16:00 GMT-41.43M1.51M751.67M
NGANorthern Genesis Acquisition Corp.16.18-0.08-0.49%16:00 GMT-41.18M2.17M646.09M
MUDSMudrick Capital Acquisition Corporation II13.24-0.12-0.90%16:00 GMT-44.79M1.73M523.39M
FTCVFintech Acquisition Corp. V12.9-0.75-5.49%16:00 GMT-43.47M1.94M441.01M
SFTWOsprey Technology Acquisition Corp.10.07-0.01-0.10%16:00 GMT-41.32M2.34M398.08M
HOLHolicity Inc.10.57-0.33-3.03%16:00 GMT-41.66M3.11M396.37M
TSIATS Innovation Acquisitions Corp.10.3-0.14-1.34%16:00 GMT-41.18M1.15M386.25M
PSACProperty Solutions Acquisition Corp.11.69-0.89-7.07%16:00 GMT-42.07M2.24M345.05M
VIHVPC Impact Acquisition Holdings13.28-1.83-12.11%16:00 GMT-42.28M1.03M344.24M
BCTGBCTG Acquisition Corp.12.15+0.93+8.29%16:00 GMT-41.17M19.16k259.73M
THCATuscan Holdings Corp. II10.1+0.09+0.90%16:00 GMT-41.35M284.01k222.07M
RACATherapeutics Acquisition Corp.10-0.30-2.91%16:00 GMT-41.37M85.17k178.70M
TCVATCV Acquisition Corp. Class A Ordinary Shares10.6+0.60+6.00%16:00 GMT-46.48M6.48M-
GGPIUGores Guggenheim, Inc.10.01+0.01+0.05%16:00 GMT-43.55M1.70M-
SRNGUSoaring Eagle Acquisition Corp.10.59-0.14-1.30%16:00 GMT-43.25M4.86M-
CCVI-UNChurchill Capital Corp VI10.3-0.03-0.29%15:56 GMT-429.17k834.91k-
CVII-UNChurchill Capital Corp VII10.11+0.01+0.10%15:59 GMT-4216.03k2.34M-
CCV-UNChurchill Capital Corp V10.43-0.03-0.29%15:59 GMT-41.57M384.73k-
PNTM-UNPontem Corporation10.02+0.02+0.20%15:58 GMT-41.54M475.45k-
ROSS-UNRoss Acquisition Corp II10.01+0.02+0.20%16:00 GMT-41.49M913.69k-
SLAMUSlam Corp.10.03+0.05+0.50%16:00 GMT-41.30M1.36M-
PUCKGoal Acquisitions Corp.9.75+0.02+0.21%15:59 GMT-41.22M110.60k-
  • Couples would have to live with parents for over 3 years to save for a house deposit
    Yahoo Finance UK Live Video

    Couples would have to live with parents for over 3 years to save for a house deposit

    Couples that move in with their parents to save on rent would need to live in their family home for 37 months in order to save a 10% deposit of £26,700.

  • Slam Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing April 15, 2021
    PR Newswire

    Slam Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing April 15, 2021

    Slam Corp. (NASDAQ: SLAMU) (the "Company") announced that, commencing April 15, 2021, holders of the units sold in the Company's initial public offering of 57,500,000 units, completed on February 25, 2021, may elect to separately trade the Class A ordinary shares and warrants included in the units. Those units not separated will continue to trade on the Nasdaq Stock Market LLC ("NASDAQ") under the symbol "SLAMU," and the Class A ordinary shares and warrants that are separated will trade on the NASDAQ under the symbols "SLAM" and "SLAMW," respectively. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into Class A ordinary shares and warrants.

  • Cancer Biotech Tango Therapeutics Picks Boxer Capital's SPAC To Go Public Via $353M Merger

    Cancer Biotech Tango Therapeutics Picks Boxer Capital's SPAC To Go Public Via $353M Merger

    The latest biotech-SPAC deal has arrived with Cambridge, Massachusetts-based Tango Therapeutics announcing its reverse merger with Boxer Capital’s blank-check company BCTG Acquisition Corp (NASDAQ: BCTG). With a spotlight on three lead programs, Tango expects total proceeds of $353 million in the deal, including around $167 million held in the SPAC and an additional $186 million in PIPE financing. When the deal closes, Tango’s stock is expected to list on the NASDAQ under the stock symbol “TNGX.” Tango develops drugs based on synthetic lethality, a concept that involves tapping into a genetic vulnerability in cancer. Its focus is on developing drugs that counteract the loss of tumor suppressor genes and reverse cancer cells’ ability to evade the immune system. Lead program TNG908 is designed to block PRMT5, an enzyme expressed at high levels in tumors and whose synthetic lethal pair is a gene called MTAP. The company plans to file FDA investigational new drug (IND) application by the end of this year. A second IND filing is planned for next year for an inhibitor of a cancer protein called USP1, which Tango intends to develop for BRCA1-mutant breast, ovarian, and prostate cancers. The third program for an undisclosed target is expected to reach the clinic in 2023 for lung cancer characterized by a mutation to the STK11 gene. The company also plans to continue work on preclinical compounds in its pipeline to file a new IND every 12 to 18 months. In 2018, Tango signed Gilead Sciences Inc (NASDAQ: GILD) to work together on five drug targets. Last year the companies expanded the pact to encompass 15 targets, which excludes Tango’s three lead candidates. Tango and BCTG have scheduled a conference call today at 10 a.m. E.T. Price Action: BCTG shares are up 5.26% at $11.80 on the last check Wednesday. See more from BenzingaClick here for options trades from BenzingaaTyr Pharma Recruits Lonza As Manufacturing Partner For Cancer Therapy ATYR2810Moleculin Biotech Stock Is Trading Higher After WP1066 Scores Rare Pediatric Disease Tag For Type Of Brain Tumor© 2021 Benzinga does not provide investment advice. All rights reserved.